Intravenous immunoglobulin and rituximab in a treatment ‐refractory COVID‐19‐associated central nervous system vasculitis: A case report and literature review

In this study, we present the first case of treatment-refractory CNS vasculitis associated with COVID-19, which was treated successfully with intravenous immunoglobulin and rituximab. Second, we repo rt a review of COVID-19-related CNS vasculitis articles and applied treatment strategies published in English. To elucidate the mechanism of COVID-19-related CNS vasculitis, further research is needed.
Source: Clinical and Experimental Neuroimmunology - Category: Neurology Authors: Tags: REVIEW ARTICLE Source Type: research